Clinical testing for multiple endocrine neoplasia type 1 in a DNA diagnostic laboratory

Genetics in Medicine

Volumn 7, Issue 2, 2005, Pages 131-138

  Klein, Roger D ^a   Salih, Sana ^a   Bessoni, Jesse ^a   Bale, Allen E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hyperparathyroidism; MEN1; Mutation; Pancreatic islet tumor; Pituitary tumor

Indexed keywords

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EXON; FRAMESHIFT MUTATION; GENE; GENE DELETION; GENE DUPLICATION; GENE INSERTION; GENE MUTATION; HAPLOTYPE; HUMAN; HYPERPARATHYROIDISM; HYPOPHYSIS TUMOR; INTRON; MAJOR CLINICAL STUDY; MEN1 GENE; MISSENSE MUTATION; MOSAICISM; MULTIPLE ENDOCRINE NEOPLASIA; NONSENSE MUTATION; PANCREAS TUMOR; PARATHYROID TUMOR; PEDIGREE; PHENOTYPE; POLYMERASE CHAIN REACTION; QUESTIONNAIRE; RNA SPLICING;

ADENOMA, ISLET CELL; DNA MUTATIONAL ANALYSIS; GENES, TUMOR SUPPRESSOR; HUMANS; HYPERPARATHYROIDISM; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PANCREATIC NEOPLASMS; PEDIGREE; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS;

EID: 13844318139     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.GIM.0000153663.62300.F8     Document Type: Article

References (40)

1. Trump D, Farren B, Wooding C, Pang JT, Besser GM et al. Clinical studies of multiple endocrine neoplasia type 1 (MEN1). QJM 1996;89:653-669.
2. Gibril F, Schumann M, Pace A, and Jensen RT. Multiple endocrine neoplasia type I and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature. Medicine 2004;83:43-83.
3. Lairmore TC, Piersall LD, DeBenedetti KM, Dilley WG, Mutch M et al. Clinical genetic testing and early surgical intervention in patients with multiple endocrine neoplasia type 1 (MEN 1). Ann Surg 2004;239:637-647.
4. Skogseid B. Multiple endocrine neoplasia type 1. Br J Surg 2003;90:383-385.
5. Agarwal SK, Burns AL, Sukhodolets KE, Kennedy PA, Obungu VH et al. Molecular Pathology of the MEN1 Gene. Ann NY Acad Sci 2004;1014:189-198.
6. Doherty GM, Olson JA, Frisella MM, Lairmore TC, Wells SA, Norton JA. Lethality of Multiple Endocrine Neoplasia Type 1. World J Surg 1998;22:581-587.
7. Marx S. Multiple Endocrine Neoplasia Type 1. In: Vogelstein B, Kinder KW, eds. The Genetic Basis of Human Cancer. New York: McGraw Hill, 2002:475-479.
8. Bassett JHD, Forbes SA, Pannett AAJ, Lloyd SE, Christie PT et al. Characterization of mutations in patients with multiple endocrine neoplasia type 1. Am J Hum Genet 1998;62:232-244.
9. Knudson A. Hereditary cancer: two hits revisited. J Cancer Res Clin Oncol 1996;122:135-140.
10. Friedman E, Sakaguchi K, Bale AE, Falchetti A, Streeten E et al. Clonality of parathyroid tumours in familial multiple endocrine neoplasia type 1. N Engl J Med 1989;321:213-218.
11. Larsson C, Skogseid B, Oberg K, Nakamura Y, Nordenskold M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 1988;332:85-87.
12. Thakker RV, Bouloux P, Wooding C, Chotai K, Broad PM, Spurr NK et al. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med 1989;321:218-224.
13. Pannett AAJ, Thakker RV. Somatic mutations in MEN1 type 1 tumors, consistent with the knudson "two-hit" hypothesis. J Clin Endocrinol Metab 2001;86:4371-4374.
14. Busygina V, Suphapeetiporn K, Marek LR, Stowers RS, Xu T, Bale A. Hypermutability in a Drosophila model for multiple endocrine neoplasia type 1. Hum Mol Genet 2004;13:2399-2408.
15. Jin S, Mao H, Schnepp RW, Sykes SM, Silva AC, D'Andrea AD, Hua X. Menin associates with FANCD2, a protein involved in repair of DNA damage. Cancer Res 2003;65:4204-4210.
16. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi S, Collins FS et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997;276:404-407.
17. The European Consortium on MEN1. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. Hum Mol Genet 1997;6:1177-1183.
18. Pannett AAJ, Thakker RV. Multiple endocrine neoplasia type 1. Endocr Relat Cancer 1999;6:449-473.
19. Teh BT. Multiple endocrine neoplasia. J Intern Med 2003;253:588-589.
20. Giraud S, Zhang CX, Serova-Sinilnikova O, Wautot V, Salandre J et al. Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. Am J Hum Genet 1998;63:455-467.
21. Turner JJO, Leotlela PD, Pannett AAJ, Forbes SA, Bassett JH et al. Frequent Occurrence of an Intron 4 Mutation in Multiple Endocrine Neoplasia Type 1. J Clin Endocrinol Metab 2002;87:2688-2693.
22. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P et al. Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2. J Clin Endocrinol Metab 2001;86:5658-5671.
23. Ciulla TA, Sklar RM, Hauser SL. A simple method for DNA purification from peripheral blood. Anal Biochem 1988;174:485-488.
24. Jeanpierre M. A rapid method for the purification of DNA from blood. Nucleic Acids Res 1987;15:9611.
25. Petty EM, Glynn M, Bale AE. Direct molecular diagnosis of multiple endocrine neoplasia type 1. In: Killeen AA ed. Molecular Pathology Protocols. Totowa, NJ: Humana Press; 2000:227-242.
26. Agarwal SK, Kester MB, Debelenko LV, Heppner C, Emmert-Buck MR et al. Germ-line mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet 1997;7:1169-1175.
27. Marx SJ, Nieman LK. Aggressive pituitary tumors in MEN1: Do they refute the two-hit model of tumorigenesis. J Clin Endocrinol Metab 2002;87:453-456.
28. Clerici T, Schmid C, Komminoth P, Lange J, Spinas GA, Brandle M. 10 Swiss kindreds with multiple endocrine neoplasia type 1: assessment of screening methods. Swiss Med Wkly 2001;131:381-386.
29. Kopp I, Bartsch D, Wild A, Schilling T, Nies C, Bergenfelz A et al. Predictive Genetic Screening and Clinical Findings in Multiple Endocrine Neoplasia Type 1 Families. World J Surg 2001;25:610-616.
30. Geerdink EAM, Van der Luijt RB, Lips CJM. Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening? Eur J Endocrinol 2003;149:577-582.
31. Skogseid B, Eriksson B, Gudmar L, Lorelius LE, Rastad J, Wide L et al. Multiple endocrine neoplasia type 1: A 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 1991;73:281-287.
32. Dean PG, van Heerden JA, Farley DR, Thompson GB, Grant CS, Harmsen WS et al. Are patients with multiple endocrine neoplasia type i prone to premature death? World J Surg 2000;24:1437-1441.
33. Teh BT, Kytola S, Farnebo F, Bergman L, Wong FK et al. Mutation analysis of the MEN1 gene in multiple endocrine neoplasia type 1, familial acromegaly and familial isolated hyperparathyroidism. J Clin Endocrinol Metab 1998;83:2621-2626.
34. Mutch MG, Dilley WG, Sanjurjo F, DeBenedetti MK, Doherty GM, Wells SA Jr et al. Germline mutations in the multiple endocrine neoplasia type 1 gene: evidence for frequent splicing defects. Hum Mutat 1999;13:175-185.
35. Cavaco BM, Domingues R, Bacelar MC, Cardoso H, Barros L, Gomes L et al. Mutational analysis of Portuguese families with multiple endocrine neoplasia type 1 reveals large germline deletions. Clin Endocrinol 2002;56:465-473.
36. Human Gene Mutation Database. Available at: http://archive.uwcm.ac.uk/ uwcm/mg/hgmd0.html. Accessed October 26, 2004.
37. Thakker RV. Multiple endocrine neoplasia type 1. Endocrinol Metab Clin 2000;29:541-567.
38. Tsukada T, Yamaguchi K, Kameya T. The MEN1 gene and associated diseases: An update. Endocr Pathol 2001;12:259-273.
39. Pannett AAJ, Kennedy AM, Turner JJO, Forbes SA, Cavaco BM, Bassett JHD et al. Multiple endocrine neoplasia type 1 (MEN 1) germline mutations in familial isolated primary hyperparathyroidism. Clin Endocrinol 2003;58:639-646.
40. Warner J, Epstein M, Sweet A, Singh D, Burgess J, Stranks S et al. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. J Med Genet 2004;41:155-160.